What You Should Know: – Wheel, an Austin, TX-based virtual care platform empowering companies to deliver consumer-centric care, announced the next generation of its virtual
Editor’s Note: Stacey Churchwell is vice president and general manager of cardiovascular diagnostics and services at Medtronic. Views are the author’s own. Artificial Intelligence, or
Dive Brief: The Food and Drug Administration has published final guidance on devices for determining the susceptibility of bacterial or fungal pathogens to different antimicrobial
Dive Brief: Abbott’s analysis of U.S. pharmacy data has shown people on GLP-1 therapy wear their FreeStyle Libre sensors more. The rise of new GLP-1
The company also plans to initiate a Phase III trial for odronextamab, which evaluates the drug in earlier lines of therapy. Image Credit: Nemes Laszlo
A handful of the largest purveyors of generic medicines have made only halting progress to ensure their drugs are accessible for patients in low- and
The Massachusetts-based biotech says this would demonstrate a clinical pathway to treat patients who lack a functional thymus. Image credit: Shutterstock/Juan Gaertner. The US Department
Prescription medicines purchased in the U.S. under a controversial government discount program amounted to $53.7 billion in 2022, an 18% increase from the previous year,
KarXT is providing a novel approach to treatment by not directly blocking dopamine receptors. Credit: Soloveva Anastasiia via www.shutterstock.com. Karuna Therapeutics has announced the submission
ModeX will receive an upfront payment of $59m to fund the Phase I trial, including development, manufacturing, and execution. Image Credit: Corona Borealis Studio /